{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:25:03Z","timestamp":1788751503488,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["CR3304"],"award-info":[{"award-number":["CR3304"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011773","name":"Conseil r\u00e9gional de Bourgogne-Franche-Comt\u00e9","doi-asserted-by":"publisher","award":["2021-Y-08290"],"award-info":[{"award-number":["2021-Y-08290"]}],"id":[{"id":"10.13039\/501100011773","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mounting evidence is identifying human cytomegalovirus (HCMV) as a potential oncogenic virus. HCMV has been detected in glioblastoma multiforme (GB). Herewith, we present the first experimental evidence for the generation of\n                    <jats:italic>CMV-Elicited Glioblastoma Cells<\/jats:italic>\n                    (CEGBCs) possessing glioblastoma-like traits that lead to the formation of glioblastoma in orthotopically xenografted mice. In addition to the already reported oncogenic HCMV-DB strain, we isolated three HCMV clinical strains from GB tissues that transformed HAs toward CEGBCs and generated spheroids from CEGBCs that resulted in the appearance of glioblastoma-like tumors in xenografted mice. These tumors were nestin-positive mostly in the invasive part surrounded by GFAP-positive reactive astrocytes. The glioblastoma immunohistochemistry phenotype was confirmed by EGFR and cMet gene amplification in the tumor parallel to the detection of HCMV IE and UL69 genes and proteins. Our results fit with an HCMV-induced glioblastoma model of oncogenesis in vivo which will open the door to new therapeutic approaches and assess the anti-HCMV treatment as well as immunotherapy in fighting GB which is characterized by poor prognosis.\n                  <\/jats:p>","DOI":"10.1038\/s41417-024-00767-7","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T09:01:45Z","timestamp":1711702905000},"page":"1070-1080","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6692-2890","authenticated-orcid":false,"given":"Joris","family":"Guyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5375-0874","authenticated-orcid":false,"given":"Sandy","family":"Haidar Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranim","family":"El Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9gane","family":"Le Quang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-5229","authenticated-orcid":false,"given":"Andreas","family":"Bikfalvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0319-7617","authenticated-orcid":false,"given":"Thomas","family":"Daubon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7993-0221","authenticated-orcid":false,"given":"Georges","family":"Herbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"767_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41586-018-0389-3","volume":"560","author":"JH Lee","year":"2018","unstructured":"Lee JH, Lee JE, Kahng JY, Kim SH, Park JS, Yoon SJ, et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations. Nature. 2018;560:243\u20137. https:\/\/doi.org\/10.1038\/s41586-018-0389-3","journal-title":"Nature"},{"key":"767_CR2","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncol. 2021;23:1231\u201351. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"767_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-virology-092818-015907","volume":"6","author":"H Zur Hausen","year":"2019","unstructured":"Zur Hausen H. Cancers in humans: a lifelong search for contributions of infectious agents, autobiographic Notes. Annu Rev Virol. 2019;6:1\u201328. https:\/\/doi.org\/10.1146\/annurev-virology-092818-015907","journal-title":"Annu Rev Virol"},{"key":"767_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730765","volume":"12","author":"R El Baba","year":"2021","unstructured":"El Baba R, Herbein G. Immune landscape of CMV infection in cancer patients: from \u201ccanonical\u201d diseases toward virus-elicited oncomodulation. Front Immunol. 2021;12:730765. https:\/\/doi.org\/10.3389\/fimmu.2021.730765","journal-title":"Front Immunol"},{"key":"767_CR5","first-page":"139","volume":"61","author":"L Geder","year":"1977","unstructured":"Geder L, Sanford EJ, Rohner TJ, Rapp F. Cytomegalovirus and cancer of the prostate: in vitro transformation of human cells. Cancer Treat Rep. 1977;61:139\u201346.","journal-title":"Cancer Treat Rep"},{"key":"767_CR6","first-page":"3347","volume":"62","author":"C Cobbs","year":"2002","unstructured":"Cobbs C, Harkins L, Samanta M, Gillespie G, Bharara S, King P, et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 2002;62:3347\u201350.","journal-title":"Cancer Res"},{"key":"767_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, et al. The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells. EBioMedicine. 2018;30:167\u201383. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.015","journal-title":"EBioMedicine"},{"key":"767_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/v10080408","volume":"10","author":"G Herbein","year":"2018","unstructured":"Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018;10:408. https:\/\/doi.org\/10.3390\/v10080408","journal-title":"Viruses"},{"key":"767_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41388-023-02709-3","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Monnien F, Abad M, Bibeau F, et al. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene. 2023;42:2031\u201345. https:\/\/doi.org\/10.1038\/s41388-023-02709-3","journal-title":"Oncogene"},{"key":"767_CR10","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1038\/s41388-023-02813-4","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba R, Haidar Ahmad S, Monnien F, Mansar R, Bibeau F, Herbein G. Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells. Oncogene. 2023;42:3047\u201361. https:\/\/doi.org\/10.1038\/s41388-023-02813-4","journal-title":"Oncogene"},{"key":"767_CR11","doi-asserted-by":"publisher","first-page":"4994","DOI":"10.3390\/cancers15204994","volume":"15","author":"F Bouezzedine","year":"2023","unstructured":"Bouezzedine F, El Baba R, Haidar Ahmad S, Herbein G. Polyploid giant cancer cells generated from human cytomegalovirus-infected prostate epithelial cells. Cancers. 2023;15:4994. https:\/\/doi.org\/10.3390\/cancers15204994","journal-title":"Cancers"},{"key":"767_CR12","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1128\/JVI.03492-13","volume":"88","author":"J-P Belzile","year":"2014","unstructured":"Belzile J-P, Stark TJ, Yeo GW, Spector DH. Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J Virol. 2014;88:4021\u201339. https:\/\/doi.org\/10.1128\/JVI.03492-13","journal-title":"J Virol"},{"key":"767_CR13","doi-asserted-by":"publisher","first-page":"8929","DOI":"10.1128\/JVI.00676-06","volume":"80","author":"J Odeberg","year":"2006","unstructured":"Odeberg J, Wolmer N, Falci S, Westgren M, Seiger \u00c5, S\u00f6derberg-Naucl\u00e9r C. Human cytomegalovirus inhibits neuronal differentiation and induces apoptosis in human neural precursor cells. J Virol. 2006;80:8929\u201339. https:\/\/doi.org\/10.1128\/JVI.00676-06","journal-title":"J Virol"},{"key":"767_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1086\/373995","volume":"187","author":"T Kossmann","year":"2003","unstructured":"Kossmann T, Morganti\u2010Kossmann MC, Orenstein JM, Britt WJ, Wahl SM, Smith PD. Cytomegalovirus production by infected astrocytes correlates with transforming growth factor\u2010\u03b2 Release. J INFECT DIS. 2003;187:534\u201341. https:\/\/doi.org\/10.1086\/373995","journal-title":"J INFECT DIS"},{"key":"767_CR15","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1128\/JVI.02161-09","volume":"84","author":"MH Luo","year":"2010","unstructured":"Luo MH, Hannemann H, Kulkarni AS, Schwartz PH, O\u2019Dowd JM, Fortunato EA. Human cytomegalovirus infection causes premature and abnormal differentiation of human neural progenitor cells. J Virol. 2010;84:3528\u201341. https:\/\/doi.org\/10.1128\/JVI.02161-09","journal-title":"J Virol"},{"key":"767_CR16","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.179143","volume":"192","author":"L Geder","year":"1976","unstructured":"Geder L, Lausch R, O\u2019Neill F, Rapp F. Oncogenic transformation of human embryo lung cells by human cytomegalovirus. Science. 1976;192:1134\u20137. https:\/\/doi.org\/10.1126\/science.179143","journal-title":"Science"},{"key":"767_CR17","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1038\/s41388-021-01715-7","volume":"40","author":"Z Nehme","year":"2021","unstructured":"Nehme Z, Pasquereau S, Haidar Ahmad S, Coaquette A, Molimard C, Monnien F, et al. Polyploid giant cancer cells, stemness and epithelial-mesenchymal plasticity elicited by human cytomegalovirus. Oncogene. 2021;40:3030\u201346. https:\/\/doi.org\/10.1038\/s41388-021-01715-7","journal-title":"Oncogene"},{"key":"767_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163447","volume":"133","author":"VA Arrieta","year":"2023","unstructured":"Arrieta VA, Dmello C, McGrail DJ, Brat DJ, Lee-Chang C, Heimberger AB, et al. Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment. J Clin Investig. 2023;133:e163447. https:\/\/doi.org\/10.1172\/JCI163447","journal-title":"J Clin Investig"},{"key":"767_CR19","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3390\/cancers14081958","volume":"14","author":"MR Pantalone","year":"2022","unstructured":"Pantalone MR, Rahbar A, S\u00f6derberg-Naucler C, Stragliotto G. Valganciclovir as add-on to second-line therapy in patients with recurrent glioblastoma. Cancers. 2022;14:1958. https:\/\/doi.org\/10.3390\/cancers14081958","journal-title":"Cancers"},{"key":"767_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585616","volume":"11","author":"T Daubon","year":"2020","unstructured":"Daubon T, Hemadou A, Romero Garmendia I, Saleh M. Glioblastoma immune landscape and the potential of new immunotherapies. Front Immunol. 2020;11:585616. https:\/\/doi.org\/10.3389\/fimmu.2020.585616","journal-title":"Front Immunol"},{"key":"767_CR21","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1158\/0008-5472.CAN-14-0296","volume":"74","author":"A Schuessler","year":"2014","unstructured":"Schuessler A, Smith C, Beagley L, Boyle GM, Rehan S, Matthews K, et al. Autologous T-cell therapy for cytomegalovirus as a consolidative treatment for recurrent glioblastoma. Cancer Res. 2014;74:3466\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0296","journal-title":"Cancer Res"},{"key":"767_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1129627","volume":"13","author":"J Alcaniz","year":"2023","unstructured":"Alcaniz J, Winkler L, Dahlmann M, Becker M, Orthmann A, Haybaeck J, et al. Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures. Front Oncol. 2023;13:1129627. https:\/\/doi.org\/10.3389\/fonc.2023.1129627","journal-title":"Front Oncol"},{"key":"767_CR23","doi-asserted-by":"publisher","first-page":"e1003366","DOI":"10.1371\/journal.ppat.1003366","volume":"9","author":"CC Rossetto","year":"2013","unstructured":"Rossetto CC, Tarrant-Elorza M, Pari GS. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) Monocytes and CD34 (+) Cells. PLoS Pathog. 2013;9:e1003366. https:\/\/doi.org\/10.1371\/journal.ppat.1003366","journal-title":"PLoS Pathog"},{"key":"767_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104056","volume":"80","author":"Z Nehme","year":"2022","unstructured":"Nehme Z, Pasquereau S, Haidar Ahmad S, El Baba R, Herbein G. Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus. eBioMedicine. 2022;80:104056. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104056","journal-title":"eBioMedicine"},{"key":"767_CR25","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/onc.2016.260","volume":"36","author":"C Battistelli","year":"2017","unstructured":"Battistelli C, Cicchini C, Santangelo L, Tramontano A, Grassi L, Gonzalez FJ, et al. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition. Oncogene. 2017;36:942\u201355. https:\/\/doi.org\/10.1038\/onc.2016.260","journal-title":"Oncogene"},{"key":"767_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.772160","volume":"12","author":"S Haidar Ahmad","year":"2021","unstructured":"Haidar Ahmad S, Pasquereau S, El Baba R, Nehme Z, Lewandowski C, Herbein G. Distinct oncogenic transcriptomes in human mammary epithelial cells infected with cytomegalovirus. Front Immunol. 2021;12:772160. https:\/\/doi.org\/10.3389\/fimmu.2021.772160","journal-title":"Front Immunol"},{"key":"767_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdz029","volume":"1","author":"T Daubon","year":"2019","unstructured":"Daubon T, Guyon J, Raymond A-A, Dartigues B, Rudewicz J, Ezzoukhry Z, et al. The invasive proteome of glioblastoma revealed by laser-capture microdissection. Neuro-Oncol Adv. 2019;1:vdz029. https:\/\/doi.org\/10.1093\/noajnl\/vdz029","journal-title":"Neuro-Oncol Adv"},{"key":"767_CR28","doi-asserted-by":"publisher","unstructured":"Guyon J, Andrique L, Pujol N, R\u00f8sland GV, Recher G, Bikfalvi A, et al. A 3D Spheroid Model for Glioblastoma. JoVE:60998. https:\/\/doi.org\/10.3791\/60998 (2020).","DOI":"10.3791\/60998"},{"key":"767_CR29","doi-asserted-by":"publisher","first-page":"31955","DOI":"10.18632\/oncotarget.7454","volume":"7","author":"S Bougnaud","year":"2016","unstructured":"Bougnaud S, Golebiewska A, Oudin A, Keunen O, Harter PN, M\u00e4der L, et al. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma. Oncotarget. 2016;7:31955\u201371. https:\/\/doi.org\/10.18632\/oncotarget.7454","journal-title":"Oncotarget"},{"key":"767_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08480-y","volume":"10","author":"T Daubon","year":"2019","unstructured":"Daubon T, L\u00e9on C, Clarke K, Andrique L, Salabert L, Darbo E, et al. Deciphering the complex role of thrombospondin-1 in glioblastoma development. Nat Commun. 2019;10:1146. https:\/\/doi.org\/10.1038\/s41467-019-08480-y","journal-title":"Nat Commun"},{"key":"767_CR31","doi-asserted-by":"publisher","first-page":"7784","DOI":"10.4049\/jimmunol.0803800","volume":"182","author":"KA Khan","year":"2009","unstructured":"Khan KA, Coaquette A, Davrinche C, Herbein G. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages. J Immunol. 2009;182:7784\u201394. https:\/\/doi.org\/10.4049\/jimmunol.0803800","journal-title":"J Immunol"},{"key":"767_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03532-y","volume":"12","author":"X Chen","year":"2021","unstructured":"Chen X, Guo Z-Q, Cao D, Chen Y, Chen J. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1\/FAK\/Akt signaling. Cell Death Dis. 2021;12:244. https:\/\/doi.org\/10.1038\/s41419-021-03532-y","journal-title":"Cell Death Dis"},{"key":"767_CR33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.omtn.2021.03.018","volume":"24","author":"B Yadav","year":"2021","unstructured":"Yadav B, Pal S, Rubstov Y, Goel A, Garg M, Pavlyukov M, et al. LncRNAs associated with glioblastoma: From transcriptional noise to novel regulators with a promising role in therapeutics. Mol Ther - Nucleic Acids. 2021;24:728\u201342. https:\/\/doi.org\/10.1016\/j.omtn.2021.03.018","journal-title":"Mol Ther - Nucleic Acids"},{"key":"767_CR34","doi-asserted-by":"publisher","unstructured":"Ratliff M, Karimian-Jazi K, Hoffmann DC, Rauschenbach L, Simon M, Hai L, et al. Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression. Neuro-Oncol. 109. https:\/\/doi.org\/10.1093\/neuonc\/noad109 (2023).","DOI":"10.1093\/neuonc\/noad109"},{"key":"767_CR35","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3389\/fimmu.2018.01345","volume":"9","author":"HN Haspels","year":"2018","unstructured":"Haspels HN, Rahman MA, Joseph JV, Gras Navarro A, Chekenya M. Glioblastoma stem-like cells are more susceptible than differentiated cells to natural killer cell lysis mediated through killer immunoglobulin-like receptors\u2013human leukocyte antigen ligand mismatch and activation receptor\u2013ligand interactions. Front Immunol. 2018;9:1345. https:\/\/doi.org\/10.3389\/fimmu.2018.01345","journal-title":"Front Immunol"},{"key":"767_CR36","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.3390\/cancers14174271","volume":"14","author":"R El Baba","year":"2022","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Diab-Assaf M, Herbein G. Oncogenic and stemness signatures of the high-risk HCMV strains in breast cancer progression. Cancers. 2022;14:4271. https:\/\/doi.org\/10.3390\/cancers14174271","journal-title":"Cancers"},{"key":"767_CR37","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3390\/v14112462","volume":"14","author":"G Herbein","year":"2022","unstructured":"Herbein G. High-risk oncogenic human cytomegalovirus. Viruses. 2022;14:2462. https:\/\/doi.org\/10.3390\/v14112462","journal-title":"Viruses"},{"key":"767_CR38","doi-asserted-by":"publisher","first-page":"9211","DOI":"10.1158\/0008-5472.CAN-09-1622","volume":"69","author":"M-L Suv\u00e0","year":"2009","unstructured":"Suv\u00e0 M-L, Riggi N, Janiszewska M, Radovanovic I, Provero P, Stehle J-C, et al. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009;69:9211\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1622","journal-title":"Cancer Res"},{"key":"767_CR39","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","volume":"112","author":"S Sander","year":"2008","unstructured":"Sander S, Bullinger L, Klapproth K, Fiedler K, Kestler HA, Barth TFE, et al. MYC stimulates EZH2 expression by repression of its negative regulator miR-26a. Blood. 2008;112:4202\u201312. https:\/\/doi.org\/10.1182\/blood-2008-03-147645","journal-title":"Blood"},{"key":"767_CR40","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52483","volume":"9","author":"Z Nie","year":"2020","unstructured":"Nie Z, Guo C, Das SK, Chow CC, Batchelor E, Simons SS, et al. Dissecting transcriptional amplification by MYC. eLife. 2020;9:e52483. https:\/\/doi.org\/10.7554\/eLife.52483","journal-title":"eLife"},{"key":"767_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0252-9","volume":"31","author":"N Ahani","year":"2014","unstructured":"Ahani N, Shirkoohi R, Rokouei M, Alipour Eskandani M, Nikravesh A. Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues. Med Oncol. 2014;31:252. https:\/\/doi.org\/10.1007\/s12032-014-0252-9","journal-title":"Med Oncol"},{"key":"767_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/ng.127","volume":"40","author":"I Ben-Porath","year":"2008","unstructured":"Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell\u2013like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499\u2013507. https:\/\/doi.org\/10.1038\/ng.127","journal-title":"Nat Genet"},{"key":"767_CR43","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1073\/pnas.1400283111","volume":"111","author":"Y-W Lou","year":"2014","unstructured":"Lou Y-W, Wang P-Y, Yeh S-C, Chuang P-K, Li S-T, Wu C-Y, et al. Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers. Proc Natl Acad Sci USA. 2014;111:2482\u20137. https:\/\/doi.org\/10.1073\/pnas.1400283111","journal-title":"Proc Natl Acad Sci USA"},{"key":"767_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-32","volume":"6","author":"R Veselska","year":"2006","unstructured":"Veselska R, Kuglik P, Cejpek P, Svachova H, Neradil J, Loja T, et al. Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer. 2006;6:32. https:\/\/doi.org\/10.1186\/1471-2407-6-32","journal-title":"BMC Cancer"},{"key":"767_CR45","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/0008-5472.CAN-17-1961","volume":"78","author":"Y Li","year":"2018","unstructured":"Li Y, Zhong C, Liu D, Yu W, Chen W, Wang Y, et al. Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition. Cancer Res. 2018;78:230\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-1961","journal-title":"Cancer Res"},{"key":"767_CR46","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1128\/JVI.00188-11","volume":"85","author":"S Kondo","year":"2011","unstructured":"Kondo S, Wakisaka N, Muramatsu M, Zen Y, Endo K, Murono S, et al. Epstein-Barr virus latent membrane protein 1 induces cancer stem\/progenitor-like cells in nasopharyngeal epithelial cell lines. J Virol. 2011;85:11255\u201364. https:\/\/doi.org\/10.1128\/JVI.00188-11","journal-title":"J Virol"},{"key":"767_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10493-6","volume":"10","author":"D Henrik Heiland","year":"2019","unstructured":"Henrik Heiland D, Ravi VM, Behringer SP, Frenking JH, Wurm J, Joseph K, et al. Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun. 2019;10:2541. https:\/\/doi.org\/10.1038\/s41467-019-10493-6","journal-title":"Nat Commun"},{"key":"767_CR48","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.it.2020.07.004","volume":"41","author":"MV Sofroniew","year":"2020","unstructured":"Sofroniew MV. Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity. Trends Immunol. 2020;41:758\u201370. https:\/\/doi.org\/10.1016\/j.it.2020.07.004","journal-title":"Trends Immunol"},{"key":"767_CR49","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/onc.2014.29","volume":"34","author":"CV Camacho","year":"2015","unstructured":"Camacho CV, Todorova PK, Hardebeck MC, Tomimatsu N, Gil Del Alcazar CR, Ilcheva M, et al. DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification. Oncogene. 2015;34:1064\u201372. https:\/\/doi.org\/10.1038\/onc.2014.29","journal-title":"Oncogene"},{"key":"767_CR50","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1158\/0008-5472.CAN-19-0680","volume":"79","author":"PK Todorova","year":"2019","unstructured":"Todorova PK, Fletcher-Sananikone E, Mukherjee B, Kollipara R, Vemireddy V, Xie X-J, et al. Radiation-Induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high-grade gliomas. Cancer Res. 2019;79:3749\u201361. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-0680","journal-title":"Cancer Res"},{"key":"767_CR51","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3389\/fimmu.2019.02717","volume":"10","author":"VA Polito","year":"2019","unstructured":"Polito VA, Cristantielli R, Weber G, Del Bufalo F, Belardinilli T, Arnone CM, et al. Universal ready-to-use immunotherapeutic approach for the treatment of cancer: expanded and activated polyclonal \u03b3\u03b4 memory T cells. Front Immunol. 2019;10:2717. https:\/\/doi.org\/10.3389\/fimmu.2019.02717","journal-title":"Front Immunol"},{"key":"767_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/vaccines8010089","volume":"8","author":"J Koenig","year":"2020","unstructured":"Koenig J, Theobald SJ, Stripecke R. Modeling human cytomegalovirus in humanized mice for vaccine testing. Vaccines. 2020;8:89. https:\/\/doi.org\/10.3390\/vaccines8010089","journal-title":"Vaccines"},{"key":"767_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coviro.2015.06.006","volume":"13","author":"LB Crawford","year":"2015","unstructured":"Crawford LB, Streblow DN, Hakki M, Nelson JA, Caposio P. Humanized mouse models of human cytomegalovirus infection. Curr Opin Virol. 2015;13:86\u201392. https:\/\/doi.org\/10.1016\/j.coviro.2015.06.006","journal-title":"Curr Opin Virol"},{"key":"767_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01051-5","volume":"7","author":"LB Crawford","year":"2017","unstructured":"Crawford LB, Tempel R, Streblow DN, Kreklywich C, Smith P, Picker LJ, et al. Human cytomegalovirus induces cellular and humoral virus-specific immune responses in humanized BLT mice. Sci Rep. 2017;7:937. https:\/\/doi.org\/10.1038\/s41598-017-01051-5","journal-title":"Sci Rep."},{"key":"767_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/neuonc\/not140","volume":"16","author":"M Vidone","year":"2014","unstructured":"Vidone M, Alessandrini F, Marucci G, Farnedi A, De Biase D, Ricceri F, et al. Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme. Neuro-Oncol. 2014;16:298\u2013302. https:\/\/doi.org\/10.1093\/neuonc\/not140","journal-title":"Neuro-Oncol"},{"key":"767_CR56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1615\/CritRevOncog.2019032655","volume":"24","author":"S Zavala-Vega","year":"2019","unstructured":"Zavala-Vega S, Palma-Lara I, Ortega-Soto E, Trejo-Solis C, De Arellano IT-R, Ucharima-Corona LE, et al. Role of Epstein-Barr virus in glioblastoma. Crit Rev Oncog. 2019;24:307\u201338. https:\/\/doi.org\/10.1615\/CritRevOncog.2019032655","journal-title":"Crit Rev Oncog"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00767-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00767-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T19:03:01Z","timestamp":1721329381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-024-00767-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,29]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["767"],"URL":"https:\/\/doi.org\/10.1038\/s41417-024-00767-7","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,29]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. A written informed consent for participation was obtained from all patients. The study was authorized by the local ethics committees of Besan\u00e7on University Hospital (Besan\u00e7on, France) and the French Research Ministry (AC-2015-2496, CNIL n\u00b01173545, NF-S-138 96900 n\u00b0F2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}